PDGFRB and ductal breast carcinoma in situ: IHC analysis of two DCIS cohorts demonstrated indeed good prognosis trends for stromal PDGFRα and could identify a significant poor prognosis association, particularly for cases with high PDGFRβ expression combined with low PDGFRα level [67].